AgBiome is a privately held, product-oriented biotechnology company focused on delivering the best early-stage research and discovery to the agriculture industry. AgBiome's first product is a biological that controls the predominant soil-borne diseases of greenhouse and major row crops. AgBiome is also applying state-of-the-art genomics and screening technologies to identify plant-associated microbes that enhance plant health, pest resistance and yield.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 04/11/13 | $14,500,000 | Series A |
ARCH Venture Partners Harris & Harris Group Innotech Advisers Polaris Partners | undisclosed |
| 08/20/15 | $34,500,000 | Series B |
ARCH Venture Partners Bill & Melinda Gates Foundation Harris & Harris Group Innotech Advisers Monsanto Growth Ventures Polaris Partners Pontifax Syngenta Ventures The University of Texas Investment Management Company | undisclosed |
| 09/14/21 | $116,000,000 | Series D |
Blue Horizon Capital Novalis LifeSciences | undisclosed |
